QUICK ANSWER
Beta-2 globulin is a fraction on the serum protein electrophoresis (SPEP) test. It is not a single protein. It is a beta-region fraction that may include lipoproteins and immune-related proteins, and it can also be affected by proteins that migrate near the beta/gamma region, including some immunoglobulins. Transferrin is mainly associated with the beta-1 fraction, so beta-1 and beta-2 should be interpreted separately when both are reported.
High beta-2 globulin means that more protein than expected is migrating in the beta-2 zone. Mild elevation is usually non-specific and may reflect inflammation, infection, immune activity, lipoprotein-related changes, or nearby beta/gamma immunoglobulin migration. It should not be interpreted by itself.
| Beta-2 globulin result | Interpretation |
|---|---|
| Below lab range | Low — uncommon; interpret with total protein, albumin, beta-1, and gamma fractions |
| Within lab range | Normal for that laboratory and method |
| Slightly above range | Mild/borderline elevation — often non-specific; review full SPEP pattern |
| Clearly above range | Evaluate for inflammation, infection, lipoprotein changes, or abnormal protein migration |
| Elevated + M-spike or abnormal protein band | Needs clinical follow-up; immunofixation may be appropriate |
Common questions at a glance:
| Question | Short answer |
|---|---|
| What is beta-2 globulin? | The second beta fraction on a serum protein electrophoresis; a beta-region pattern, not one single protein |
| Is high beta-2 globulin serious? | Not always — mild/borderline elevations are often non-specific |
| What does "beta-2 globulin high" mean? | More protein migrating in the beta-2 zone — interpret with the full SPEP pattern |
| Is beta-2 globulin the same as beta-2 microglobulin? | No — they are completely different tests; see the disambiguation section |
| What is a normal beta-2 globulin level? | Varies by laboratory and method — on many split beta-2 SPEP reports the range is approximately 0.2–0.5 g/dL; always check your lab's stated range |
WHAT IS BETA-2 GLOBULIN? — READING YOUR SPEP RESULT
Serum protein electrophoresis (SPEP) separates proteins in the blood by electrical charge into distinct bands or fractions. The standard fractions reported are: Albumin, Alpha-1, Alpha-2, Beta-1, Beta-2, and Gamma.
Beta-2 globulin is the second of the two beta fractions. The proteins primarily found in the beta-2 zone include:
| Protein or protein group | Where it usually appears | Why it matters |
|---|---|---|
| Beta-lipoproteins | Classically associated with the beta-2 region | Can contribute to the beta-2 fraction depending on method and lipid status |
| Complement proteins, especially C3 | Beta region; may affect beta-2/beta-gamma area | Can increase during acute-phase or inflammatory responses |
| Immunoglobulins, especially IgA | Often beta/gamma or beta region | Monoclonal IgA can migrate in the beta region and may mimic or distort beta fractions |
| Transferrin | Primarily beta-1 | Important for distinguishing beta-1 elevation from beta-2 elevation |
| Fibrinogen artifact | Beta-gamma region if plasma contamination or incomplete clotting | Can create an apparent band that is not a true serum beta-2 globulin abnormality |
Because different laboratories and electrophoresis methods separate the beta region differently, beta-2 globulin should be interpreted as a pattern-based SPEP finding rather than as one single protein.
Your report may show beta-2 globulin as:
- An absolute value in g/dL (e.g., 0.6 g/dL)
- A relative percentage of total protein (e.g., 8.2%)
- Both absolute and relative values
- "Beta-2" alone, or "Beta-2 globulin," or "Beta 2 globulins" — all the same measurement
What does it mean if beta-1 and beta-2 are reported separately? Older analyzers sometimes report only a combined "beta" fraction. Newer analyzers separate the beta zone into beta-1 and beta-2 sub-fractions. Transferrin is primarily associated with the beta-1 zone; the beta-2 zone is more associated with beta-lipoproteins and proteins migrating near the beta/gamma boundary, including some immunoglobulins and complement proteins depending on the method. When both are reported separately, a rise in beta-2 specifically should be interpreted alongside beta-1 and the full SPEP pattern — not as equivalent to a transferrin or complement change alone.
BETA-2 GLOBULIN VS BETA-2 MICROGLOBULIN — CRITICAL DISAMBIGUATION
These two tests are frequently confused because they share similar names. They are completely different analytes measuring different things:
| Feature | Beta-2 Globulin (SPEP fraction) | Beta-2 Microglobulin (B2M) |
|---|---|---|
| What it is | A fraction on the serum protein electrophoresis — a zone containing multiple proteins | A specific single small protein (11.8 kDa) shed from cell surfaces |
| Test type | Part of SPEP panel | Standalone serum or urine test |
| Normal range | Often 0.2–0.5 g/dL on split beta-2 SPEP reports; varies by lab and method | 0.8–2.4 mg/L serum (varies by lab) |
| Units | g/dL or % | mg/L or µg/mL |
| Primary clinical use | Interpreting beta-region SPEP pattern changes and possible abnormal protein migration | Hematologic malignancy staging (multiple myeloma, lymphoma, CLL) and kidney function monitoring |
| What elevation means | Inflammation, infection, immune activation, rarely monoclonal protein | Hematologic malignancy burden, kidney dysfunction, inflammation |
| How ordered | As part of SPEP (protein electrophoresis) | As a separate standalone test: "Beta-2 Microglobulin, Serum" or "B2M" |
If your report shows "Beta-2 Microglobulin" with units of mg/L: This is the standalone B2M test, not the SPEP fraction. See the dedicated B2M section below for interpretation.
If your report shows "Beta-2 Globulin" or "Beta 2" with units of g/dL or %: This is the SPEP fraction — read the sections above and below for interpretation.
YOUR SPECIFIC BETA-2 GLOBULIN VALUE — WHAT DOES IT MEAN?
| Beta-2 globulin value (g/dL) | Interpretation |
|---|---|
| Below 0.2 g/dL | Low — uncommon; evaluate with total protein, albumin, beta-1, and gamma |
| 0.2–0.5 g/dL | Within the typical split beta-2 SPEP range for many labs |
| 0.5–0.6 g/dL | At or just above the upper limit on many split beta-2 reports; borderline |
| 0.6 g/dL | Often borderline or mildly elevated on split beta-2 reports using a 0.2–0.5 g/dL range; may be within range if your lab uses a wider method-specific range |
| 0.7–0.9 g/dL | Mildly elevated on most split beta-2 ranges — evaluate full SPEP pattern; often non-specific |
| 1.0 g/dL and above | Clearly above most split beta-2 reference ranges — evaluate alongside full SPEP pattern; consider inflammation, immune activation, lipoprotein changes, or abnormal protein migration |
| Elevated + M-spike or abnormal band | Requires clinical follow-up; immunofixation appropriate |
Is beta-2 globulin 0.6 high? It depends on the reference range printed on your lab report. On many split beta-1/beta-2 SPEP reports, beta-2 globulin has a reference range around 0.2–0.5 g/dL, so 0.6 g/dL would be slightly high or borderline elevated. This is usually not alarming by itself. If your lab uses a wider range and does not flag 0.6, it may be considered normal for that method. The most important next step is to review the full SPEP pattern, including beta-1, gamma globulin, albumin, total protein, and whether an M-spike or abnormal protein band was reported.
What does "beta-2 globulin leicht erhöht" (mildly elevated) mean? A mildly elevated beta-2 globulin on a split SPEP report usually means the value is slightly above the lab's stated upper limit for that fraction. This is most commonly a non-specific finding that may reflect low-grade inflammation, infection, immune activity, or lipoprotein-related changes. It is not a specific finding on its own and should be interpreted alongside the full SPEP pattern and clinical context.
WHAT DOES HIGH BETA-2 GLOBULIN MEAN?
High beta-2 globulin means that more protein than expected is migrating in the beta-2 zone of the electrophoresis. Because the beta-2 fraction reflects a mixture of proteins — including beta-lipoproteins, some immunoglobulins, and complement-related proteins depending on the method — elevation is non-specific and should always be interpreted alongside the full SPEP pattern.
Common causes of high beta-2 globulin:
| Cause | Mechanism | Notes |
|---|---|---|
| Recent or active inflammation | Acute-phase and immune-related proteins may alter the beta region | Common and often temporary |
| Infection | Immune activation can change beta and gamma fractions | Interpret with CRP, CBC, symptoms, and gamma globulin |
| Autoimmune or chronic inflammatory disease | Persistent immune activation may affect beta/gamma patterns | Often accompanied by other inflammatory markers |
| Lipoprotein-related changes | Beta-lipoproteins can contribute to the beta-2 region | May be relevant when cholesterol or triglycerides are abnormal |
| Monoclonal IgA or other abnormal protein migration | Some monoclonal proteins migrate in the beta region rather than gamma | Look for M-spike, abnormal protein band, or immunofixation result |
| Liver disease or systemic illness | Alters multiple serum protein fractions | Usually not isolated to beta-2 |
| Sample or method artifact | Plasma contamination or incomplete clotting can create fibrinogen banding | Consider if the pattern does not fit the clinical picture |
High beta-2 globulin and cancer: A mildly elevated beta-2 globulin fraction on SPEP does not diagnose cancer. Most mild elevations reflect inflammatory or immune causes. When hematologic malignancy produces SPEP abnormalities, it typically produces other distinctive changes — a visible M-spike, hypogammaglobulinemia, or characteristic pattern changes — not isolated beta-2 elevation alone.
WHAT DOES LOW BETA-2 GLOBULIN MEAN?
Low beta-2 globulin means the beta-2 fraction is below the laboratory's stated reference range. On many split beta-2 SPEP reports this may mean below approximately 0.2 g/dL, but the exact cutoff depends on the lab method. Low beta-2 is less commonly emphasized than elevation and may indicate:
| Cause | Notes |
|---|---|
| Protein malnutrition | Reduced overall protein production reduces all fractions |
| Severe liver disease | Reduced synthetic capacity may affect multiple serum protein fractions |
| Primary immune deficiency | May affect immune-related protein patterns, usually with other abnormalities |
| Protein-losing conditions | Nephrotic syndrome, protein-losing enteropathy — loss of multiple proteins |
| Hereditary complement deficiency | Rare; usually evaluated with specific complement testing rather than SPEP alone |
Low beta-2 globulin in isolation, without other electrophoresis abnormalities or clinical symptoms, is usually not clinically significant.
MOST COMMON BETA-2 GLOBULIN RESULTS
| Result | Typical interpretation |
|---|---|
| Within lab range | Normal for that laboratory and method — no action needed |
| Just above lab range | Borderline/mild — review full SPEP pattern; often non-specific |
| Clearly above lab range | Evaluate for inflammation, infection, lipoprotein changes, or abnormal protein migration |
| Significantly elevated | Evaluate alongside full SPEP pattern; consider M-protein if other abnormalities present |
| Below lab range | Low — evaluate nutritional status, liver function, and other SPEP fractions |
INTERPRETING BETA-2 ALONGSIDE THE FULL SPEP PATTERN
Beta-2 globulin is most meaningful when read in context with the other SPEP fractions. Common patterns:
| Pattern | Most likely interpretation |
|---|---|
| High beta-2 + normal gamma | Non-specific beta-region change; possible recent inflammation, infection, lipoprotein-related change, or method-related variation |
| High beta-2 + high gamma (polyclonal) | Chronic infection, autoimmune disease, or chronic inflammation pattern |
| High beta-2 + M-spike in gamma or beta region | Monoclonal gammopathy — further evaluation with immunofixation |
| High beta-2 + low albumin | Systemic inflammation, liver disease, protein loss, or severe illness pattern |
| High beta-1 + high beta-2 | Broader beta-region increase — consider iron status/transferrin, inflammation, lipoprotein-related changes, and abnormal protein migration |
| Low beta-2 + low gamma | Immunodeficiency or significant protein loss |
| High alpha-2 + high beta-2 | Possible acute-phase/inflammatory pattern; interpret with CRP, albumin, and clinical context |
| High beta-2 + normal everything else | Often borderline/non-specific; clinical correlation and repeat testing may be appropriate |
BETA-2 MICROGLOBULIN (B2M) — STANDALONE TEST INTERPRETATION
Beta-2 microglobulin (B2M) is a completely different test from the SPEP beta-2 fraction. It measures a specific small protein (beta-2 microglobulin) that is shed from the surface of all nucleated cells. It is measured as a standalone serum or urine test, not as part of SPEP.
Normal range for B2M (serum): Approximately 0.8–2.4 mg/L — reference ranges vary by laboratory and may be age-adjusted.
Primary uses of B2M:
| Clinical use | Details |
|---|---|
| Multiple myeloma staging | B2M is part of the International Staging System (ISS) for myeloma — higher B2M indicates more advanced disease |
| Lymphoma monitoring | Elevated in follicular lymphoma, diffuse large B-cell lymphoma, and CLL |
| Chronic lymphocytic leukemia (CLL) | Prognostic marker; higher B2M associated with more active disease |
| Kidney function assessment | B2M is filtered by the glomerulus and reabsorbed by tubules; elevates in both reduced GFR and tubular dysfunction |
| HIV monitoring | Elevated in active HIV infection; correlates with viral load |
B2M interpretation by level: The cutoffs below are most useful when B2M is being used in the context of known or suspected plasma-cell or lymphoid disease. They are not standalone cancer-diagnosis thresholds. Kidney function, inflammation, infection, and age can all affect B2M.
| B2M serum level | Interpretation |
|---|---|
| Within your lab's reference range | Usually normal |
| Mildly above range | Commonly related to kidney function, inflammation, infection, autoimmune disease, or hematologic disease context |
| 3.5–5.5 mg/L | Important range in multiple myeloma staging; clinical interpretation depends on albumin and the broader workup |
| Above 5.5 mg/L | Used as an ISS Stage III threshold in multiple myeloma staging; requires clinician follow-up in the right clinical context |
What causes high B2M?
| Cause | Notes |
|---|---|
| Multiple myeloma | Major clinical use; elevated in proportion to disease burden |
| Lymphoma | Elevated in non-Hodgkin lymphoma subtypes |
| CLL | Prognostic marker |
| Reduced kidney function / CKD | GFR reduction impairs B2M clearance — very common cause of mild B2M elevation |
| Active inflammation / infection | Cell turnover increases B2M release |
| HIV infection | Elevated with active viral replication |
| Autoimmune disease | Chronic immune activation |
| Renal tubular dysfunction | Impaired tubular reabsorption causes B2M accumulation even with normal GFR |
How to reduce high B2M: B2M cannot be reduced directly — treatment focuses on the underlying cause. In myeloma or lymphoma, effective treatment reduces B2M as disease burden decreases. In kidney disease, optimizing kidney function and treating underlying causes may stabilize or reduce B2M. In inflammation, treating the inflammatory condition often reduces B2M.
WHEN SHOULD I WORRY ABOUT HIGH BETA-2 GLOBULIN?
| Situation | Concern level | Recommended action |
|---|---|---|
| Beta-2 mildly elevated (just above lab range) + known infection or inflammation | Low | Expected finding; recheck after underlying condition treated |
| Beta-2 mildly elevated + otherwise normal SPEP | Low | Clinical correlation; likely inflammatory; recheck in 3–6 months |
| Beta-2 elevated + M-spike visible on SPEP | Moderate-High | Immunofixation and hematology evaluation |
| Beta-2 elevated + hypogammaglobulinemia | Moderate | Evaluate for immune deficiency or hematologic condition |
| Beta-2 elevated + high gamma (polyclonal) | Low-Moderate | Evaluate for chronic infection or autoimmune disease |
| Beta-2 persistently elevated over multiple tests | Moderate | Clinical evaluation for chronic inflammatory or hematologic cause |
| B2M elevated above 3.5 mg/L | Moderate-High | Hematology and nephrology evaluation depending on context |
| B2M above 5.5 mg/L | High in myeloma-staging context | Prompt clinician follow-up; interpret with kidney function, albumin, SPEP/IFE, free light chains, CBC, calcium, and clinical history |
TREND INTERPRETATION
For HealthMatters users tracking beta-2 globulin over time:
| Pattern | Clinical meaning |
|---|---|
| Stable within normal range | No concern |
| Elevated during illness → normalizes | Reactive pattern — confirms inflammatory etiology; reassuring |
| Persistent mild elevation across multiple tests | Evaluate for low-grade chronic inflammation or autoimmune condition |
| Rising trend alongside other fraction changes | Full SPEP pattern review needed; consider hematology referral |
| Falling toward normal after treatment | Confirms response to treatment of underlying condition |
| Isolated beta-2 elevation, all other fractions normal | Usually inflammatory; monitor; repeat in 3–6 months |
Beta-2-Globulin, Serum
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
Frequently Asked Questions
What is beta-2 globulin in a blood test?
What does high beta-2 globulin mean?
Why does my lab say beta-2 globulin is high at 0.6?
Is beta-2 globulin 0.6 high?
What is the difference between beta-2 globulin and beta-2 microglobulin?
What does "bêta 2 globuline quand s'inquiéter" mean — when should I worry about elevated beta-2 globulin?
Are the 3.5 and 5.5 beta-2 microglobulin cutoffs cancer cutoffs?
What causes high beta-2 microglobulin (B2M)?
What does beta-2 globulin erhöht mean (German — elevated beta-2 globulin)?
Can high beta-2 globulin indicate cancer?
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.
-
Guidelines for clinical and laboratory evaluation patients with monoclonal gammopathies
-
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
-
Understanding and interpreting serum protein electrophoresis
-
Revised International Staging System for Multiple Myeloma: a report from IMWG